Daily Summary
In 2025, millions of Americans will benefit from lower prescription drug costs due to a new Medicare Part D out-of-pocket cap, while physicians face a 2.83% pay cut and rising administrative challenges even as some states ease prior authorization rules. Meanwhile, COVID-19 is receding as a major health threat and becoming just one of several endemic viruses. In addition, new medical breakthroughs, including advanced eye-tracking technology in surgeries and an FDA-approved schizophrenia treatment with fewer side effects, promise to enhance healthcare outcomes.
2024's Top Health Stories and Their Outlook for 2025
As COVID-19 fades — now the 10th leading cause of death in the U.S. — key health trends from 2024, including shifts in funding and regulatory changes, are shaping a new normal heading into 2025.
Good News, Bad News for Physicians Facing 2025
Physicians face a challenging 2025 with a finalized 2.83% pay cut and rising administrative burdens, although state reforms and a return to private practice signal some promise.
Millions of Americans to Benefit from New $2,000 Medicare Drug Cost Cap in 2025
Starting in January 2025, Medicare Part D enrollees will see a cap of $2,000 on prescription drug out-of-pocket expenses, potentially saving millions more than $1,000 annually, despite industry warnings of possible higher premiums and reduced treatment access.
Top 12 Medical Breakthroughs for Enhanced Health in 2025
Upcoming breakthroughs for 2025 include an innovative eye-tracking technology to aid surgical precision and the FDA's approval of Cobenfy, a new schizophrenia treatment with fewer side effects.